Researchers have identified a causal genetic variant strongly associated with childhood obesity. The study provides new insight into the importance of the hypothalamus of the brain and its role in common childhood obesity and the target gene may serve as a druggable target for future therapeutic interventions.
A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.
Event at National Press Club features nutrition, food safety scientists and leaders addressing major issues with a research and regulatory lens.
As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, Progentec’s proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are available.
The Leapfrog Group has granted University of Chicago Medical Center (UCMC) its 25th consecutive “A” Hospital Safety Grade, making it one of only 15 hospitals nationwide and the only one in Chicago with the “straight A” distinction.
Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute.
Long non-coding RNAs (lncRNAs) are ubiquitous transcripts with crucial regulatory roles in various biological processes, including chromatin remodeling, post-transcriptional regulation, and epigenetic modifications.
International collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update consensus harmonized guidelines on several key subjects in oncology, including how best to treat people with both cancer and HIV.
The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement to strengthen cancer prevention and control initiatives across the Americas. The event took place in Washington, D.C., with leaders from both organizations.
A. Sonia Buist, MD, a past president of the American Thoracic Society and an advocate for global public health policy and respiratory health, has donated $400,000 to the Society, making her the ATS’s highest lifetime donor in its history. Her gift will support the ATS/MECOR Women’s Leadership Program, a new visionary program to enhance leadership capabilities in African women.
The American Cancer Society today released a first-of-its-kind Cancer Facts & Figures for Asian American, Native Hawaiian, & Other Pacific Islander People, 2024-2026. This report shows that despite limited disaggregated data, there is wide variation in the cancer burden among ethnic groups that make up this fast-growing population.
UC Davis study of data from 8500+ ICU patients finds more out-of-bed mobility interventions for critically ill patients were associated with shorter mechanical ventilation duration and hospital stays, suggesting a dose-response relationship between daily mobility and patient outcomes.
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.
Announcement of contents of the May 2024 issue of Neurosurgical Focus
Keck Hospital of USC earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national watchdog organization.
Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac ultrasound videos, and their corresponding clinical interpretations. Using this database, they created EchoCLIP, a powerful machine learning algorithm that can “interpret” echocardiogram images and assess key findings.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for April 2024.
Rates of HIV transmission increased when the U.S./Mexico border was closed for COVID-19, according to a new study from University of California San Diego and Irvine.
A Doença de Pick, uma doença neurodegenerativa de origem genética desconhecida, é um tipo raro de demência frontotemporal que afeta pessoas com menos de 65 anos. A condição causa mudanças na personalidade, no comportamento e, às vezes, compromete a linguagem. Em pacientes com a doença, as proteínas Taus se acumulam e formam aglomerados anormais chamados de corpos de Pick, que restringem os nutrientes ao cérebro e causam neurodegeneração.
A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated.
The American Association of Neurological Surgeons (AANS) is thrilled to announce the impressive lineup of esteemed speakers set to headline the highly anticipated 2024 AANS Annual Scientific Meeting, taking place from May 3-5 in the vibrant city of Chicago.
Media representatives are invited to attend and cover this prestigious gathering, which will feature a comprehensive program of presentations, lectures, panel discussions and hands-on workshops covering the latest advancements, research, techniques and breakthroughs in neurosurgery — including artificial intelligence and how it is transforming neurosurgery.
La enfermedad de Pick, una enfermedad neurodegenerativa de origen genético desconocido, es un tipo raro de demencia frontotemporal que afecta a personas menores de 65 años. La condición causa cambios en la personalidad, en el comportamiento y, a veces, compromete el lenguaje. En pacientes con la enfermedad, las proteínas Taus se acumulan y forman grupos anormales llamados cuerpos Pick, que restringen los nutrientes al cerebro y causan neurodegeneración.
Hackensack Meridian Mountainside Medical Center is proud to announce the successful completion of its first bronchoscopy procedure using the Ion Endoluminal System, a cutting-edge robotic-assisted technology designed for minimally invasive lung biopsies.
مرض بيك، المرض التنكسي العصبي ذو الأصل الوراثي غير المعروف، هو خرف جبهي صدغي يؤثر على الأشخاص تحت سن 65 عامًا. تتسبب الحالة في حدوث تغييرات في الشخصية والسلوك واضطراب في اللغة أحيانًا. بالنسبة للمرضى المصابون بهذا المرض، تتراكم بروتينات تاو وتشكل كتلًا غير طبيعية تسمى أجسام بيك؛ التي تعمل على تقييد وصول العناصر المغذية إلى الدماغ وتسبب تنكسًا عصبيًا. والطريقة الوحيدة لتشخيص المرض هي فحص أنسجة الدماغ تحت المجهر بعد وفاة الشخص.
Mitchell Schnall, MD, PhD, has been appointed to a newly created role as Senior Vice President for Data and Technology Solutions for the University of Pennsylvania Health System (UPHS), following two terms as Chair of Radiology in Penn’s Perelman School of Medicine. In his new role, he will lead teams and projects that will pave a path for Penn Medicine to lead the health care industry into a new, technology- and data-driven era.
Preoperative Botox injections are a useful test for predicting how well patients with chronic migraine will respond to nerve decompression surgery, reports a study in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
In an effort to improve delivery of costly medical treatments, a team of researchers in electrical engineering at the University of Wisconsin–Madison has developed a stimulating method that could make the human body more receptive to certain gene therapies.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right